Newsroom

JACKSON, Miss.--(BUSINESS WIRE)--The Federal Home Loan Bank of Dallas (FHLB Dallas), through its member Community Bank of Mississippi (Community Bank), awarded a $150,000 Pathway Fund grant to Mission First Inc. (Mission First) to help expand services to accessible, affordable legal aid in Hinds, Madison and Rankin counties in Mississippi. The grant, awarded today during a ceremonial check presentation at Community Bank’s offices in Jackson, Mississippi, will help Mission First assist homeowner...

OTTAWA, Ontário--(BUSINESS WIRE)--A Kinaxis® Inc. (TSX:KXS), líder global em orquestração de cadeia de suprimentos, anunciou hoje que agendou sua teleconferência para discutir os resultados financeiros do seu quarto trimestre e do ano concluído em 31 de dezembro de 2025. A teleconferência acontecerá na quinta-feira, 5 de março, às 8h30 (horário do leste), presidida por Razat Gaurav, CEO, e Blaine Fitzgerald, diretor financeiro, com tempo para perguntas e respostas. A empresa divulgará seus resu...

PARIS LA DÉFENSE--(BUSINESS WIRE)--Regulatory News: Elior Group (Paris:ELIOR): I - LEGAL FRAMEWORK OF THE SHARE BUYBACK PROGRAM The share buyback program is governed by the applicable laws and regulations. It was authorized by the shareholders at the Annual General Meeting of Elior Group (the “Company”) held on February 4, 2026 (the “AGM”) in the terms mentioned in the Notice of Meeting as published on December 26, 2025 in the France’s Official Legal Journal (“BALO”) and displays the features d...

PARIS LA DÉFENSE--(BUSINESS WIRE)--Regulatory News: Elior Group (Paris:ELIOR): I - CADRE JURIDIQUE DU PROGRAMME DE RACHAT D’ACTIONS Le programme de rachat d’actions propres s’inscrit dans le cadre des dispositions légales et règlementaires applicables. Ce programme a été soumis à l’autorisation de l’assemblée générale mixte d’Elior Group (la « Société ») du 4 février 2026 (l’« AGM ») dans les termes publiés dans le cadre de l’avis préalable paru au BALO du 26 décembre 2025 et qui présente les c...

LOS ANGELES--(BUSINESS WIRE)--During today’s Nintendo Direct, SQUARE ENIX announced PARANORMASIGHT: The Mermaid's Curse, the second installment in the series, following the cult hit PARANORMASIGHT: The Seven Mysteries of Honjo, is coming to Nintendo Switch™ and other major platforms on Feb. 19. The company also revealed that FINAL FANTASY VII REBIRTH, the acclaimed sequel and second game in the FINAL FANTASY VII remake series, is coming to Nintendo Switch™ 2, Xbox Series X|S and Xbox on PC on J...

加オンタリオ州オタワ--(BUSINESS WIRE)--（ビジネスワイヤ） -- サプライチェーン・オーケストレーションの世界的リーダーのキナクシス (TSX：KXS)は、2025年12月31日を期末とする第4四半期および通期の決算に関する電話会議の開催を発表しました。電話会議は3月5日（木）午前8時30分（東部標準時）に、最高経営責任者（CEO）のラザット・ガウラヴと最高財務責任者（CFO）のブレーン・フィッツジェラルドが司会を務め、その後質疑応答が行われます。第4四半期および通期の業績は、2026年3月4日（水）の市場取引終了後に発表されます。 電話会議の詳細 日付： 2026年3月5日（木） 時刻： 午前8時30分（東部標準時） ウェブキャスト： https://events.q4inc.com/attendee/567578009（3か月間再生可能） キナクシスについて キナクシスは、現代のサプライチェーン・オーケストレーションのリーダーとして、複雑なグローバル・サプライチェーンを支え、それを管理する人々を支援しています。当社の強力なAIを組み込んだサプライチェーン・オーケ...

NEW ORLEANS--(BUSINESS WIRE)--Bayer today presented the results from the global, pivotal Phase III OCEANIC-STROKE study evaluating the use of its investigational, once-daily, oral, Factor XIa inhibitor asundexian (50mg) compared to placebo, both in combination with antiplatelet therapy. Asundexian significantly reduced ischemic stroke by 26% (csHR 0.74; 95% CI 0.65–0.84; p<.0001), in patients after a non-cardioembolic ischemic stroke or high-risk transient ischemic attack, with no increase i...

OTTAWA, Ontario--(BUSINESS WIRE)--Kinaxis® Inc. (TSX:KXS), leader mondiale nell'orchestrazione della catena di fornitura, oggi ha annunciato di aver programmato una teleconferenza per presentare i risultati finanziari del quarto trimestre e della fine dell'anno conclusosi il 31 dicembre 2025. La teleconferenza verrà ospitata giovedì 5 marzo alle 8:30 (ora della costa orientale) da Razat Gaurav, CEO, e da Blaine Fitzgerald, direttore finanziario. Alla teleconferenza seguirà una sessione di doman...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between August 3, 2023 and December 26, 2025. Ultragenyx describes itself as a “biopharmaceutical company focused on rare and ultrarare genetic disorders.” For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investig...

OTTAWA, Ontario--(BUSINESS WIRE)--Kinaxis® Inc. (TSX : KXS), leader mondial de l’orchestration de la chaîne d’approvisionnement, a annoncé aujourd’hui avoir prévu une téléconférence pour discuter de ses résultats financiers pour le quatrième trimestre et l’année clos le 31 décembre 2025. La téléconférence aura lieu le jeudi 5 mars à 8h30, heure de l’Est, et sera animée par Razat Gaurav, président-directeur général, et Blaine Fitzgerald, directeur financier, puis sera suivie d’une séance de ques...